| 引用本文:张向磊1，卢立伟1，刘阳1，魏小雪1，李勇2.基于中医传承辅助平台的中医药治疗乙肝肝硬化用药规律分析[J].世界中医药,2016,(10):. |
|
| 基于中医传承辅助平台的中医药治疗乙肝肝硬化用药规律分析 |
| Analysis on Medicinal Combination Rule for Liver Cirrhosis due to Chronic Hepatitis B by Traditional Chinese Medicine Inheritance Platform System |
| 投稿时间：2015-12-20 |
| DOI：10.3969/j.issn.1673-7202.2016.10.060 |
| 中文关键词: 中医传承辅助平台 乙肝肝硬化 用药规律 |
| English Keywords:TCM Inheritance Platform System Liver cirrhosis due to chronic hepatitis B Combination rules of medicinals |
| 基金项目:国家中医临床研究基地业务建设科研专项（编号：JDZX2012065）；山东省自然科学基金项目(编号：ZR2015PH055）；山东省青少年教育科学规划课题大学生学术课题（编号：16BSH048） |
|
| 摘要点击次数: 793 |
| 全文下载次数: 670 |
| 中文摘要: |
| 目的：应用中医传承辅助平台分析中医药治疗乙肝肝硬化方剂的组方用药规律。方法：收集近10年来中国期刊全文数据库(CNKI)中涉及中医药治疗乙肝肝硬化的文献，运用中医传承辅助平台中集成的数据挖掘方法，分析方剂中药物的用药规律。结果：共筛选出符合标准的文献319篇，收集到治疗乙肝肝硬化的253条方剂记录，分析得出核心药物组合28个，挖掘出新处方共14个。结论：通过中医传承辅助平台可对乙肝肝硬化方剂数据进行数据挖掘，使复杂的用药规律清晰简明有序，对研究中医药治疗乙肝肝硬化有很大的帮助。 |
| English Summary: |
| To explain the combination rules of medicinal for liver cirrhosis due to chronic hepatitis B collected in CNKI by traditional Chinese medicine (TCM) inheritance Platform System. Methods: The prescriptions used for liver cirrhosis due to chronic hepatitis B in CNKI were collected and input into the TCM inheritance Platform System. TCM inheritance Platform System was used to explore the combination rules of medicinal in prescriptions for liver cirrhosis resulting from chronic hepatitis B. Results: The combination rules of medicinal were extracted based on the analysis of 253 cases of prescriptions by TCM inheritance Platform System. The frequent-used herbs were analyzed. Twenty-eight main combinations and 14 new prescriptions were extracted. Conclusion: The complex combination rules of medicinal in prescriptions for liver cirrhosis due to chronic hepatitis B collected in CNKI have been clarified by TCM inheritance Platform System, which is helpful to study the treatment of Chinese TCM for liver cirrhosis due to chronic hepatitis B. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
